Cellectar Biosciences Inc (CLRB)
3.30
-0.03
(-0.90%)
USD |
NASDAQ |
May 17, 16:00
3.295
0.00 (0.00%)
Pre-Market: 20:00
Cellectar Biosciences 1 Year Total Returns (Daily): 127.6% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 127.6% |
May 16, 2024 | 139.9% |
May 15, 2024 | 143.5% |
May 14, 2024 | 127.1% |
May 13, 2024 | 118.6% |
May 10, 2024 | 119.3% |
May 09, 2024 | 128.2% |
May 08, 2024 | 120.7% |
May 07, 2024 | 125.3% |
May 06, 2024 | 128.1% |
May 03, 2024 | 126.5% |
May 02, 2024 | 115.5% |
May 01, 2024 | 100.0% |
April 30, 2024 | 100.6% |
April 29, 2024 | 101.3% |
April 26, 2024 | 107.4% |
April 25, 2024 | 104.1% |
April 24, 2024 | 112.5% |
April 23, 2024 | 110.1% |
April 22, 2024 | 115.5% |
April 19, 2024 | 96.12% |
April 18, 2024 | 92.41% |
April 17, 2024 | 103.2% |
April 16, 2024 | 136.4% |
April 15, 2024 | 137.1% |
Date | Value |
---|---|
April 12, 2024 | 152.5% |
April 11, 2024 | 168.8% |
April 10, 2024 | 154.7% |
April 09, 2024 | 168.3% |
April 08, 2024 | 174.1% |
April 05, 2024 | 178.5% |
April 04, 2024 | 163.8% |
April 03, 2024 | 172.6% |
April 02, 2024 | 179.0% |
April 01, 2024 | 174.1% |
March 28, 2024 | 180.3% |
March 27, 2024 | 142.3% |
March 26, 2024 | 155.0% |
March 25, 2024 | 156.3% |
March 22, 2024 | 169.1% |
March 21, 2024 | 152.9% |
March 20, 2024 | 147.0% |
March 19, 2024 | 148.7% |
March 18, 2024 | 120.4% |
March 15, 2024 | 128.9% |
March 14, 2024 | 113.9% |
March 13, 2024 | 126.9% |
March 12, 2024 | 125.5% |
March 11, 2024 | 134.2% |
March 08, 2024 | 110.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.40%
Minimum
May 20 2019
180.3%
Maximum
Mar 28 2024
-23.52%
Average
-35.81%
Median
Jul 28 2020
1 Year Total Returns (Daily) Benchmarks
Perspective Therapeutics Inc | 252.7% |
Eli Lilly and Co | 77.30% |
Actinium Pharmaceuticals Inc | 16.81% |
Bristol-Myers Squibb Co | -30.98% |
Altimmune Inc | 74.13% |